DoH Policies screened during the period: 1 April 2017 – 30 June 2017 | Department of Health

In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact assessment (EQIA).

Documents

Amendment of General Dental Services Regulations (NI) 1993 (“the GDS Regulations”)
PDF (174 KB)

NICE Public Health Guideline NG58 - Coexisting severe mental illness and substance misuse: community health and social care services
PDF (163 KB)

NICE Public Health Guideline NG60 - HIV testing: increasing uptake among people who may have undiagnosed HIV
PDF (152 KB)

NICE Public Health Guideline NG64 - Drug misuse prevention: targeted interventions
PDF (173 KB)

NICE Clinical Guideline NG65 - Spondyloarthritis in over 16s: diagnosis and management
PDF (160 KB)

NICE Clinical Guideline NG66 - Mental health of adults in contact with the criminal justice system
PDF (162 KB)

NICE Public Health Guideline NG68 - Sexually transmitted infections: condom distribution schemes
PDF (161 KB)

NICE Public Health Guideline PH51 - Contraceptive services for under 25s
PDF (149 KB)

NICE Technology Appraisal TA439 - Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (review of TA176 & part review of TA240)
PDF (155 KB)

NICE Technology Appraisal TA440 - Pegylated liposomal irinotecan hydrochloride trihydrate for treating pancreatic cancer after gemcitabine
PDF (169 KB)

NICE Technology Appraisal TA441 - Daclizumab for treating relapsing-remitting multiple sclerosis
PDF (67 KB)

NICE Technology Appraisal TA442 - Ixekizumab for treating moderate to severe plaque psoriasis
PDF (161 KB)

NICE Technology Appraisal TA443 - Obeticholic acid for treating primary biliary cholangitis
PDF (150 KB)

NICE Technology Appraisal TA445 - Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs
PDF (70 KB)

Help viewing documents